A patient with stage III HER2-negative breast cancer type, treated with 1.5 mg/kg/day propranolol for 18 days and with the daily dose reduced over subsequent 7 days, after the treatment period, had the tumor removed surgically [77]. Here, ERBB2 is linked to breast carcinoma.